Cincinnati Rheumatic Disease Study Group — Cincinnati, Ohio

Cincinnati Rheumatic Disease Study Group is a clinical research site located in Cincinnati, Ohio, United States 45219.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Cincinnati Rheumatic Disease Study Group has participated in 11 clinical trials.

Therapeutic areas: Rheumatoid Arthritis (RA), Rheumatoid Arthritis, Systemic Lupus Erythematosus.

Sponsors: Bristol-Myers Squibb, R-Pharm International, LLC, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cincinnati Rheumatic Disease Study Group?

Cincinnati Rheumatic Disease Study Group has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cincinnati Rheumatic Disease Study Group conducted?

Cincinnati Rheumatic Disease Study Group has 11 clinical trials on record. Their work covers Rheumatoid Arthritis (RA), Rheumatoid Arthritis, Systemic Lupus Erythematosus.

Is Cincinnati Rheumatic Disease Study Group accredited by Crixeo Health?

Yes — Cincinnati Rheumatic Disease Study Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cincinnati Rheumatic Disease Study Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.